Vanguard Group Inc Clene Inc. Transaction History

Vanguard Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.31 - $0.44 $760 - $1,079	2,454 Added 0.09%	2,622,157 $943,000
Q1 2024 May 10, 2024	BUY	$0.28 - $0.53 $368 - $696	1,315 Added 0.05%	2,619,703 $1.13 Million
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.55 $44,842 - $94,859	172,471 Added 7.05%	2,618,388 $785,000
Q3 2023 Nov 14, 2023	BUY	$0.46 - $0.87 $112,948 - $213,619	245,540 Added 11.16%	2,445,917 $1.22 Million
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.22 $842,088 - $1.32 Million	1,079,601 Added 96.33%	2,200,377 $1.94 Million
Q1 2023 May 15, 2023	BUY	$0.95 - $1.62 $179,282 - $305,723	188,718 Added 20.25%	1,120,776 $1.27 Million
Q4 2022 Feb 10, 2023	BUY	$0.92 - $40.2 $409 - $17,889	445 Added 0.05%	932,058 $932,000
Q3 2022 Nov 14, 2022	BUY	$0.33 - $73.0 $39,297 - $8.69 Million	119,084 Added 14.66%	931,613 $2.61 Million
Q2 2022 Aug 12, 2022	BUY	$2.1 - $4.12 $47,388 - $92,971	22,566 Added 2.86%	812,529 $2.05 Million
Q1 2022 May 13, 2022	SELL	$2.42 - $4.42 $529,670 - $967,414	-218,872 Reduced 21.7%	789,963 $3.11 Million
Q4 2021 Feb 14, 2022	SELL	$3.95 - $7.53 $454,992 - $867,365	-115,188 Reduced 10.25%	1,008,835 $4.14 Million
Q3 2021 Nov 12, 2021	SELL	$6.83 - $13.58 $55,042 - $109,441	-8,059 Reduced 0.71%	1,124,023 $7.68 Million
Q2 2021 Aug 13, 2021	BUY	$6.98 - $13.33 $7.9 Million - $15.1 Million	1,132,082 New	1,132,082 $12.7 Million

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.